secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2025-04-15T23:59:59+00:00
Accession:  0001213900-25-032176
Event type: other
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds amends bylaws: reduces quorum, eliminates written consent, raises bar for director removal
--------------------------------------------------------------------------------

- Quorum reduced from majority to 33 1/3% of outstanding shares.
- Stockholders can no longer act by written consent; removal of directors is for cause only with 66 2/3% vote.
- Advanced notice required for stockholder proposals and director nominations.
- Board size fixed between 1 and 7 directors; Delaware forum selection clause added.
- Amendments to bylaws require affirmative vote of 66 2/3% of voting power.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025032176/0001213900-25-032176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025032176/ea0238443-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-032176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer